BL&H Co.,Ltd. distributes pharmaceutical products. The company offers test kits, drugs, injections, drops, and other solutions. It also provides drug eluting beads, a medical device that is used for the embolization of vessels supplying malignant hypervascularised tumour; and TheraSphere, a medical device for radioembolization for liver malignancy. The company also develops products in the areas of antiperspirant, veno-occlusive disease, digoxin toxicity or overdose, mercury poisoning, anaphylaxis, hand and foot syndrome, acute lymphocytic leukemia, ovarian cancer, sustained reduction of toxic methotrexate, metastatic islet cell carcinoma of the pancreas, and vitamin D deficiency. In addition, it develops products in the areas of diagnosis and monitoring of toxic iron overload in serum, liver neoplasia, aqueous wound and mucous membrane antiseptic, and local anaesthetic; head and neck cancer, and Hodgkin's disease; and Rheumatoid arthritis, CINCA syndrome. It serves the needs of doctors, nurses, pharmacists, and patients in the European Union, Korea, and Canada. BL&H Co.,Ltd. was founded in 1999 and is based in Seoul, South Korea.
